FDA and Geron Corp. Reach Agreement on Spinal Injury Drug Trial Stem cell research company Geron Corp (GERN.O) said it reached an agreement with U.S. health regulators which may enable it to restart the early stage trials of its cell therapy to treat complete thoracic spinal cord injury.